| Product Code: ETC7539547 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Central Nervous System Stimulant Drugs Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Central Nervous System Stimulant Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 India Central Nervous System Stimulant Drugs Market - Industry Life Cycle |
3.4 India Central Nervous System Stimulant Drugs Market - Porter's Five Forces |
3.5 India Central Nervous System Stimulant Drugs Market Revenues & Volume Share, By Poduct Type, 2021 & 2031F |
3.6 India Central Nervous System Stimulant Drugs Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 India Central Nervous System Stimulant Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in India |
4.2.2 Growing awareness about mental health and related treatments |
4.2.3 Rise in healthcare expenditure and government initiatives to improve healthcare infrastructure |
4.3 Market Restraints |
4.3.1 Stringent government regulations and approval processes for CNS stimulant drugs |
4.3.2 Potential side effects and abuse of CNS stimulant drugs |
4.3.3 Competition from alternative therapies and treatments for neurological disorders |
5 India Central Nervous System Stimulant Drugs Market Trends |
6 India Central Nervous System Stimulant Drugs Market, By Types |
6.1 India Central Nervous System Stimulant Drugs Market, By Poduct Type |
6.1.1 Overview and Analysis |
6.1.2 India Central Nervous System Stimulant Drugs Market Revenues & Volume, By Poduct Type, 2021- 2031F |
6.1.3 India Central Nervous System Stimulant Drugs Market Revenues & Volume, By Lisdexamfetamine, 2021- 2031F |
6.1.4 India Central Nervous System Stimulant Drugs Market Revenues & Volume, By Dextroamphetamine, 2021- 2031F |
6.1.5 India Central Nervous System Stimulant Drugs Market Revenues & Volume, By Methylphenidate HCl, 2021- 2031F |
6.1.6 India Central Nervous System Stimulant Drugs Market Revenues & Volume, By Other Product Types, 2021- 2031F |
6.2 India Central Nervous System Stimulant Drugs Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 India Central Nervous System Stimulant Drugs Market Revenues & Volume, By Attention Deficit Hyperactivity Disorder (ADHD), 2021- 2031F |
6.2.3 India Central Nervous System Stimulant Drugs Market Revenues & Volume, By Sleeping Disorder, 2021- 2031F |
6.2.4 India Central Nervous System Stimulant Drugs Market Revenues & Volume, By Other Applications, 2021- 2031F |
7 India Central Nervous System Stimulant Drugs Market Import-Export Trade Statistics |
7.1 India Central Nervous System Stimulant Drugs Market Export to Major Countries |
7.2 India Central Nervous System Stimulant Drugs Market Imports from Major Countries |
8 India Central Nervous System Stimulant Drugs Market Key Performance Indicators |
8.1 Number of clinical trials and research studies conducted on CNS stimulant drugs in India |
8.2 Adoption rates of CNS stimulant drugs in different regions of India |
8.3 Patient adherence and compliance rates with CNS stimulant drug treatments |
9 India Central Nervous System Stimulant Drugs Market - Opportunity Assessment |
9.1 India Central Nervous System Stimulant Drugs Market Opportunity Assessment, By Poduct Type, 2021 & 2031F |
9.2 India Central Nervous System Stimulant Drugs Market Opportunity Assessment, By Application, 2021 & 2031F |
10 India Central Nervous System Stimulant Drugs Market - Competitive Landscape |
10.1 India Central Nervous System Stimulant Drugs Market Revenue Share, By Companies, 2024 |
10.2 India Central Nervous System Stimulant Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |